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Abstract. 
 
The integration of the vimentin intermediate
ﬁlament (IF) cytoskeleton and cellular organelles in
vivo is an incompletely understood process, and the
identities of proteins participating in such events are
largely unknown. Here, we show that the Golgi com-
plex interacts with the vimentin IF cytoskeleton, and
that the Golgi protein formiminotransferase cyclo-
deaminase (FTCD) participates in this interaction. We
show that the peripherally associated Golgi protein
FTCD binds directly to vimentin subunits and to poly-
merized vimentin ﬁlaments in vivo and in vitro. Expres-
sion of FTCD in cultured cells results in the formation
of extensive FTCD-containing ﬁbers originating from
the Golgi region, and is paralleled by a dramatic rear-
rangements of the vimentin IF cytoskeleton in a coordi-
nate process in which vimentin ﬁlaments and FTCD in-
tegrate into chimeric ﬁbers. Formation of the FTCD
ﬁbers is obligatorily coupled to vimentin assembly and
 
does not occur in vim
 
2/2
 
 cells. The FTCD-mediated
regulation of vimentin IF is not a secondary effect of
changes in the microtubule or the actin cytoskeletons,
since those cytoskeletal systems appear unaffected by
FTCD expression. The assembly of the FTCD/vimentin
ﬁbers causes a coordinate change in the structure of the
Golgi complex and results in Golgi fragmentation into
individual elements that are tethered to the FTCD/vi-
mentin ﬁbers. The observed interaction of Golgi ele-
ments with vimentin ﬁlaments and the ability of FTCD
to speciﬁcally interacts with both Golgi membrane and
vimentin ﬁlaments and promote their association sug-
gest that FTCD might be a candidate protein integrat-
ing the Golgi compartment with the IF cytoskeleton.
Key words: FTCD • vimentin • intermediate ﬁla-
ments • Golgi complex • IFAP
 
Introduction
 
Intermediate filaments (IFs)
 
1
 
 constitute one of the three
major cytoskeletal systems of eukaryotic cells. IFs are
composed of a diverse but related family of proteins
whose expression patterns are usually cell type specific
(Fuchs and Weber, 1994). Distinct groups of IFs are de-
scribed based on their assembly properties, gene structure,
and sequence homologies: the keratins, the neurofilament-
like proteins, the lamins, and the vimentin-related pro-
teins. The vimentin-related group includes vimentin,
desmin, glial fibrillary acid protein (GFAP), and periph-
erin. Vimentin is expressed predominantly in cells of mes-
enchymal origin (Franke et al., 1982) and in cells adopted
to culture (Franke et al., 1979). Desmin is required for
normal myofibrillogenesis and resistance to contractile
damage in muscle cells, since knockout mice lacking
desmin exhibit cardiovascular lesions and skeletal myopa-
thy (Li et al., 1994; Milner et al., 1996). The functional sig-
nificance of the GFAP and vimentin IF cytoskeletons are
less clear. Knockout of GFAP (Gomi et al., 1995; Pekny et
al., 1995) or vimentin (Colucci-Guyon et al., 1994) pro-
duces animals that are live and overall normal, suggesting
that elimination of these IF elements can either be com-
pensated by other cytoskeletal arrays or that they perform
more subtle cellular functions. However, GFAP-lacking
mice show changes in myelination of axons and GFAP as-
sembly (Galou et al., 1996; Liedtke et al., 1996; Shibuki et
al., 1996), whereas vimentin null animals show changes in
recovery from neuronal injury (Pekny et al., 1999) and, at
the cellular level, changes in fat granule deposition (Lieber
and Evans, 1996), glycolipid processing (Gillard et al.,
1998), and movement of low density lipoprotein–derived
cholesterol (Sarria et al., 1992).
Numerous IF-associated proteins (IFAPs) have been
described that appear to connect IFs to the actin cytoskel-
eton, to the microtubule cytoskeleton, to cell–cell and
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cell–substratum adhesion zones, and to cellular mem-
branes (Stappenbeck and Green, 1992; Stappenbeck et al.,
1993; Yang et al., 1996; for review see Chou et al., 1997;
Correia et al., 1999; Leung et al., 1999; Yang et al., 1999).
The list of IFAPs that specifically associate with vimentin
has been growing and now includes plectin (involved in
cross-linking vimentin IFs to other cytoskeletal elements
and to specialized membrane adhesion sites), filamin (an
actin binding protein that is likely to cross-link IFs to actin
cytoskeleton), fimbrin (an actin-binding protein possibly
involved in attaching IFs to cell–substrate adhesion sites),
kinesin (involved in linking IFs to microtubules), trans-
glutaminase (possibly involved in cross-linking vimentin
subunits or filaments), and various chaperones and kinases
(functions of which are not well understood at present). In
addition, vimentin IFs have been shown in electron micro-
scopic studies to lie in close spatial association with spe-
cific membranous organelles such as the nucleus, the
plasma membrane, mitochondria, and the Golgi complex
(Katsumoto et al., 1991; for review see Georgatos and
Maison, 1996). However, whether IFs are merely adjacent
to these organelles or are directly tethered by binding to as
yet unidentified surface IFAPs has not been resolved.
Here, we present the initial report of a direct association
between the Golgi complex and the vimentin IF cytoskele-
ton. The association is apparent in vivo, with Golgi ele-
ments aligned on vimentin filaments clustered around the
microtubule-organizing center (MTOC). The microtubule
cytoskeleton is not required for the IF–Golgi association,
and dispersed Golgi ministacks remain associated with vi-
mentin filaments in cells in which microtubules are dis-
rupted. Direct binding between recombinant vimentin and
isolated Golgi elements can be also demonstrated by cen-
trifugation and solid phase binding assays in vitro.
We document that the enzyme formiminotransferase cy-
clodeaminase (FTCD) localizes to the Golgi complex and
the vimentin IF cytoskeleton in vivo, and that FTCD di-
rectly interacts with vimentin filaments and Golgi mem-
branes in vitro. FTCD has been shown by us (Gao et al.,
1998) and others (Bashour and Bloom, 1998; Hennig et al.,
1998) to be identical to the 58K Golgi protein, initially
proposed to link Golgi membranes to the microtubule cy-
toskeleton (Bloom and Brashear, 1989). However, recent
reexamination of FTCD behavior indicates that FTCD
binds to polyglutamated residues preferentially found in
brain tubulin and does not interact with tubulin from other
sources (Bashour and Bloom, 1998). FTCD is found in ev-
ery cell type examined, but its expression is orders of mag-
nitude higher in the liver than in other tissues or cell types
(Bashour and Bloom, 1998; Hennig et al., 1998; Solans et
al., 2000). It is likely that within hepatocytes, FTCD has
predominantly a metabolic function, catalyzing two se-
quential reactions in the histidine degradation pathway.
The FT domain of this bifunctional enzyme first transfers
the formimino group of formiminoglutamate to tetra-
hydrofolate to produce formiminotetrahydrofolate and
glutamate, and then the CD domain catalyzes the cycliza-
tion of the folate intermediate to produce methenyltet-
rahydrofolate and releasing ammonia (for review see
Shane and Stokstad, 1984).
 
 
 
However, the function of
FTCD in tissues and cells that are not major sites for histi-
dine metabolism has not been explored. We now report
 
that FTCD facilitates interactions between the Golgi com-
plex and the IF cytoskeleton. We show that FTCD pro-
motes the binding of isolated Golgi elements to vimentin
in vitro, and that expression of FTCD in vivo dramatically
changes the overall structure of the vimentin IF cytoskele-
ton and causes a coordinate disruption of Golgi structure.
Based on our results, we propose that FTCD is a candidate
linker protein connecting the Golgi complex to the vimen-
tin IF cytoskeleton. 
 
Materials and Methods
 
Reagents and Antibodies
 
Restriction enzymes and molecular reagents were from Promega, New
England BioLabs, Inc., or QIAGEN. Rat liver 
 
l
 
 ZAP II cDNA expres-
sion library and Pfu DNA polymerase were from Stratagene. All other
chemicals were from Sigma-Aldrich or Fisher Scientific. A hybridoma cell
line (58K-9) was a gift of Dr. George Bloom (University of Texas South-
western Medical Center, Dallas, TX) and was used to generate ascites in
mice. IgGs were purified from ascites by affinity adsorption as described
previously (Gao et al., 1998). Polyclonal rabbit serum raised against por-
cine FTCD was a gift of Dr. Robert MacKenzie (McGill University, Mon-
treal, Quebec). mAbs against vimentin (clone V9) and against 
 
b
 
-tubulin
(clone TUB 2.1) were from Sigma-Aldrich. mAb to mouse vimentin
(clone 9.5) was provided by Dr. Robert Evans (University of Colorado,
Denver, CO). Polyclonal goat antibody against human vimentin was from
ICN Biomedicals. Polyclonal rabbit antibodies against GM130 have been
described previously (Nelson et al., 1998). Monoclonal antigiantin anti-
body was a kind gift of Dr. Hans-Peter Hauri (University of Basel, Basel,
Switzerland). Oregon green–labeled goat anti–rabbit IgG antibody, Texas
red–labeled goat anti–mouse IgG antibody, FITC-labeled goat anti–
mouse IgM antibody, Texas red–labeled goat anti–rabbit IgG antibody
were from Molecular Probes, Inc. HRP-labeled sheep anti–rabbit IgG an-
tibody, HRP-labeled donkey anti–mouse IgG antibody, and HRP-labeled
rabbit anti–goat IgG antibody were from Amersham Pharmacia Biotech.
SuperSignal West Pico chemiluminescence substrate was from Pierce
Chemical Co. EIA/RIA 96-well microtiter plates were from Corning, Inc.
 
Cells
 
COS-7 cells were grown in DME with glucose and glutamine (Mediatech,
Inc.) supplemented with 10% FBS (Life Technologies), 100 U/ml penicil-
lin, and 100 
 
m
 
g/ml streptomycin (Life Technologies). Normal rat kidney
(NRK) cells were grown in the same medium, except the concentration of
FBS was 5%. Mouse cell line MFT-6 (vim
 
1
 
) and the cell line MFT-16
(vim
 
2/2
 
) derived from a vimentin knockout mouse were provided by Dr.
Robert Evans. MFT-6 (vim
 
1
 
) and MFT-16 (vim
 
2/2
 
) cells were grown in
1:1 Ham’s F12 (with glutamine; Mediatech, Inc.): DME (with glucose and
glutamine), supplemented with 5% FBS and 10 
 
m
 
g/ml Gentamycin (Medi-
atech, Inc.). Mouse NIH3T3 cells stably expressing green fluorescent pro-
tein (GFP)–vimentin were provided by Drs. Gregg Gundersen and Ron
Liem (Columbia University, New York, NY), grown in DME with 10%
FBS, streptomycin, and penicillin as above, and supplemented with 300
 
m
 
g/ml G418 sulfate (Life Technologies).
 
Subcellular Fractionation of COS-7 Cells
 
COS-7 cells were grown in two 150-mm dishes to 70% confluency and were
transfected with 35 
 
m
 
g of GFP-rFTCD plasmid per plate using the calcium
phosphate transfection system (Life Technologies). 48 h after transfection,
cells were washed (four times, 2 min each) with prechilled HKM (25 mM
Hepes, pH 7.4, 115 mM potassium acetate, 2.5 mM magnesium chloride)
and scraped from plates. Collected cells (in 
 
z
 
1 ml solution) were supple-
mented with 10 
 
m
 
l protease inhibitor cocktail (Sigma-Aldrich) and passed
through a 26G3/8 needle (Becton Dickinson) 20 times on ice. The cell ly-
sate was centrifuged at 1,500 
 
g
 
 for 10 min at 4
 
8
 
C. The resulting postnuclear
supernatant was mixed with 2 M sucrose in HKM to a final concentration
of 1.6 M sucrose. The mixture was loaded at the bottom of a centrifuge
tube and overlaid with 1.3, 1.0, 0.8, and 0.5 M sucrose in HKM. Equilibrium
centrifugation was carried out in SW41 Ti rotor (Beckman Coulter) at
135,000 
 
g
 
 for 14 h at 4
 
8
 
C. Fractions were collected from the top. 
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DNA Cloning
 
Cloning and partial sequencing of rat FTCD were performed as described
previously (Gao et al., 1998). A full-length FTCD clone in vector pBlue-
script SK(
 
2
 
) (Stratagene) was obtained and named rFTCD–pBS. For
cloning into pcDNA 3.1(
 
1
 
) (Invitrogen), the full-length rFTCD cDNA
was cut out from rFTCD–pBS using BamHI–XhoI sites and was inserted
at the corresponding sites in pcDNA 3.1(
 
1
 
). The construct was named
rFTCD–pcDNA. To make a chimera of GFP and FTCD (GFP–rFTCD),
the coding sequence of FTCD was amplified by PCR with rFTCD–pBS as
the template. A BglII site was created upstream from the start codon, and
a HindIII site was created at the stop codon, destroying it. The PCR frag-
ment was inserted into pEGFP-C2 vector (CLONTECH Laboratories,
Inc.) at the BglII–HindIII sites. FTCD was at the COOH terminus of GFP
and was in frame. There were seven amino acids between GFP and the
first methionine of FTCD, and 18 amino acids between the last amino acid
of FTCD (glutamic acid) and the new stop codon provided by the vector.
A full-length FTCD was also cloned into a bacterial expression system as
follows: the FTCD sequence was amplified by PCR, using rFTCD–pBS as
the template, using a T7 primer as the 3
 
9
 
 end reverse primer and a 5
 
9
 
 end
forward primer containing a NdeI site before the start codon. The coding
portion was cut with NdeI and EcoRI from the PCR product and was
cloned into pET-21b (Novagen). This construct was named rFTCD–pET.
 
In Vitro Transcription/Translation of FTCD
 
In vitro translation of rFTCD–pBS was carried out using the TNT T7-cou-
pled reticulocyte lysate system from Promega, according to the manufac-
turer directions. 2 
 
m
 
g of rFTCD–pBS cDNA was used in a total reaction
volume of 100 
 
m
 
l. Trans 
 
35
 
S label from ICN Biomedicals was used as the
source of [
 
35
 
S]methionine and [
 
35
 
S]cysteine. The reaction was carried out
at 30
 
8
 
C for 4 h.
 
Expression and Purification of Recombinant FTCD 
from Bacteria
 
rFTCD–pET was transfected into BL21 (DE3) cells (Novagen) by standard
protocol. A single colony was grown in 1 liter of medium at 30
 
8
 
C until
 
OD
 
600
 
 reached 1.0. IPTG (Fisher Scientific) was then added to 0.5 mM, and
the culture was grown for another 3 h at 30
 
8
 
C. The cells were collected by
centrifugation at 4,500 
 
g
 
 for 10 min and washed once with PBS. FTCD was
purified according to a previously published protocol (Murley et al., 1993),
with minor modification. All steps were performed on ice or at 4
 
8
 
C. In
short, cells were resuspended in 0.1 M potassium phosphate (pH 7.3), 35
mM 
 
b
 
-mercaptoethanol, and 1 mM PMSF, sonicated for 30 s for five times
with 1-min intervals. The sonicated material was supplemented with Triton
X-100 to 0.02% concentration, mixed and centrifuged at 27,000 
 
g
 
 for 30 min.
The collected supernatant was supplemented with 10% volume of 250 mM
MOPS (pH 7.3) and 24% volume of glycerol, then with ammonium sulfate
to 40% saturation, and precipitation was carried out with stirring overnight.
The mixture was centrifuged at 27,000 
 
g
 
 for 30 min, and the resulting pellet
was resuspended in 5 ml buffer A (25 mM MOPS, pH 7.3, 5 mM potassium
phosphate, pH 7.3, 5% glycerol, 35 mM 
 
b
 
-mercaptoethanol, 0.02% Triton
X-100, and 1 mM PMSF, which was added freshly). The resuspended pellet
was dialyzed two times against 500 ml buffer A and clarified at 27,000 
 
g
 
 for
30 min. The resulting supernatant was loaded onto a 1.6- 
 
3
 
 18-cm DEAE
Sepharose Fast Flow (Amersham Pharmacia Biotech) column equilibrated
with buffer A. Proteins were eluted with a linear gradient of buffer A and
equal volume of 0.3 M potassium chloride in buffer A at 22 ml/h. Collected
fractions were analyzed by SDS-PAGE and immunoblotting with anti-
FTCD antibodies. The formiminotransferase activity of DEAE-purified
FTCD was comparable to that of purified pig FTCD (data not shown; Mur-
ley et al., 1993). The DEAE-purified FTCD was further purified using Ciba-
cron blue 3Ga column followed by a Heparin column, according to a previ-
ously described protocol (Murley et al., 1993). Collected fractions were
analyzed by SDS-PAGE and immunoblotting with anti-FTCD antibodies.
Fractions containing the peak of FTCD by immunoblotting were pooled
and analyzed by SDS-PAGE and Coomassie brilliant blue R-250 staining
(see Fig. 2 A).
 
Transfections and Immunofluorescence Microscopy
 
COS-7 cells were transfected with the calcium phosphate transfection sys-
tem (Life Technologies) or with TransIT polyamine transfection reagents
(Mirus Corporation), according to manufacturer protocols. Other cells
were transfected with the TransIT polyamine transfection reagent. 18–
 
48 h after transfection, cells were fixed with 3% paraformaldehyde and
processed for immunofluorescence microscopy as previously described
(Alvarez et al., 1999). In some experiments, the cells were fixed and per-
meabilized with 
 
2
 
20
 
8
 
C methanol for 20 min at 
 
2
 
20
 
8
 
C. All following steps
were as described (Alvarez et al., 1999). Actin filaments were visualized
by labeling with phalloidin-FITC (Molecular Probes, Inc.) diluted with
0.4% fish skin gelatin, 0.05% Tween 20 in PBS. In some cases, cells were
treated with nocodazole (Sigma-Aldrich) at 10 
 
m
 
g/ml from a 10 mg/ml
DMSO stock. The treatment was at 37
 
8
 
C for periods indicated in figure
legends. In experiments analyzing the localization of endogenous FTCD
and vimentin, COS-7 cells were first washed with prechilled HKM buffer
and then treated with 40 
 
m
 
g/ml digitonin in HKM for 5 min on ice (Plutner
et al., 1992), followed by washing with HKM (three times, 2 min each) and
fixing with 3% paraformaldehyde as above.
 
SDS-PAGE and Immunoblotting
 
Samples were analyzed by SDS-PAGE as described previously (Sztul et
al., 1985). After SDS-PAGE, proteins were transferred to NitroPure ni-
trocellulose (NC) membrane (Micron Separations Inc.), and the mem-
brane was subjected to immunoblotting as previously described (Gao et
al., 1998). In some cases, NC membranes were striped at 50
 
8
 
C for 30 min
in 62.5 mM Tris-HCl (pH 6.7), 100 mM 
 
b
 
-mercaptoethanol, and 2% SDS,
washed with 0.05% Tween 20 in TBS (TBS-T), blocked in 7.5% nonfat
milk–TBS-T, and reprobed with another antibody.
 
Overlay Assay
 
Proteins were analyzed by SDS-PAGE and were transferred to NC mem-
brane, which was blocked with 1% BSA–HKM-0.05% Tween 20. The
membrane was then incubated for 2 h at room temperature with 40 
 
m
 
l in
vitro transcribed/translated FTCD diluted in the blocking buffer. After
washing with HKM, the membrane was dried in air and exposed to X-ray
film.
 
Expression and Purification of Recombinant Mouse 
Vimentin from Bacteria
 
Plasmid pCMV-Vim, a gift from Dr. Robert Evans was used as the PCR
template. A NdeI and a BamHI site were introduced at the 5
 
9
 
 and the 3
 
9
 
end of the coding region of vimentin. The amplified cDNA was then
cloned into pET-21b vector and transfected into BL21 (DE3) cells as de-
scribed above. Induction was with 0.5 mM IPTG at 37
 
8
 
C for 3.5 h. Vimen-
tin purification was carried out according to the method described previ-
ously (Domingo et al., 1991). In short, bacteria were collected and treated
with lysozyme and DNase I. Cells were lysed with a detergent buffer (20
mM Tris-HCl, pH 7.5, 0.2 M NaCl, 1% deoxycholic acid, 1% NP-40, 10
mM NaF, and 2 mM EDTA). Inclusion bodies were recovered by centrif-
ugation at 5,000 
 
g
 
 for 15 min at 4
 
8
 
C. After washing with Triton buffer (10
mM Tris-HCl, pH 7.5, 0.5% Triton X-100, 1 mM EDTA, 0.1 M NaCl), the
inclusion bodies were dissolved in urea solution (8 M urea in 50 mM Tris-
HCl and 10 mM DTT, pH 8.0). The solubilized material was loaded on a
DEAE–Sepharose Fast Flow column (2.6 
 
3
 
 18 cm), which had been equil-
ibrated with urea solution, and was eluted with a linear NaCl gradient
from 0–500 mM made in urea solution. Fractions enriched in vimentin
were pooled, and proteins were precipitated with solid ammonium sulfate
to 60% saturation. The precipitates were collected by centrifugation at
25,000 
 
g 
 
for 15 min, redissolved in urea solution, and dialyzed against 10
mM Tris-HCl (pH 7.4) and 0.1% 
 
b
 
-mercaptoethanol. The dialyzed vimen-
tin was further centrifuged at 100,000 
 
g
 
 in type 60Ti rotor (Beckman
Coulter) for 30 min at 4
 
8
 
C to clear precipitates. Vimentin was recovered in
the supernatant and was 
 
$
 
95% pure as judged by Coomassie blue staining
of an SDS-PAGE gel.
 
Binding of FTCD to Vimentin Filaments
 
To avoid nonspecific sedimentation, all protein materials used in binding
experiments were preclarified at 125,000 
 
g
 
 for 30 min at 20
 
8
 
C. To polymer-
ize vimentin filaments, recombinant mouse vimentin at 
 
z
 
2 mg/ml was
mixed with NaCl to a final concentration of 0.15 M NaCl and incubated in
a 35
 
8
 
C waterbath for 40 min. For in vitro association, 4 
 
m
 
g preformed vi-
mentin filaments was incubated with buffer or with different amounts of
bacterially expressed and purified FTCD. In some experiments 0.25 
 
m
 
g
BSA in buffer was used
 
 
 
as a control. The reactions were carried out at
room temperature for 2.5 h in 20 
 
m
 
l solution that also contained 25 mM
Hepes (pH 7.4), 115 mM potassium acetate, 5 mM 
 
b
 
-mercaptoethanol, 
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0.02% Triton X-100, and 2% glycerol. The mixtures were then centrifuged
at 100,000 
 
g 
 
in TLA 45 rotor (Beckman Coulter) at 20
 
8
 
C for 30 min. Su-
pernatants and pellets were recovered, and equal amounts of supernatants
and pellets were processed for SDS-PAGE and immunoblotting with anti-
FTCD antibodies. The amount of material loaded on the gel was adjusted
so that a similar amount of FTCD was analyzed in each binding group.
 
 
 
An
analogous binding experiment was carried out for EM, except that 0.06 
 
m
 
g
recombinant FTCD was used. After incubation, the solution was applied
to Farmvar-coated grids and stained with 1% uranyl acetate. The samples
were examined on a Hitachi 7000 transmission electron microscope at ac-
celerating voltage of 75 kV.
 
Binding of Vimentin to Golgi Elements
 
Rat liver stacked Golgi (SG) fraction was isolated as described before
(Nelson et al., 1998). The SG fraction was made 40% nycodenz (Life
Technologies) in HKM and overlaid with 36 and 32% nycodenz–HKM.
Upfloatation was carried out in SW50.1 rotor (Beckman Coulter) at
135,000 
 
g
 
 for 7 h. Enriched Golgi fractions were identified by immuno-
blotting with anti-GM130 antibodies. The fractions were pooled, and the
protein concentration was 
 
z
 
650 
 
m
 
g/ml. 100-
 
m
 
l Golgi fraction was diluted
with 170 
 
m
 
l HKM buffer and then supplemented either with 5 
 
m
 
l buffer or
5 
 
m
 
l buffer containing 10 
 
m
 
g purified recombinant mouse vimentin. The
mixtures were incubated at 4
 
8
 
C for 3 h, supplemented with 2 M sucrose in
HKM to a final sucrose concentration of 1.6 M, and were loaded at a bot-
tom of centrifuge tubes. The load was overlaid with 1.3 and 0.8 M sucrose
in HKM, and the tubes were centrifuged in SW 50.1 rotor at 
 
z
 
135,000 
 
g
 
for 7 h. Fractions were collected from top of the gradient. Fractions 3 and
4 were pooled, supplemented with 2 M sucrose in HKM to 1.6 M final con-
centration, and subjected to another round of equilibrium centrifugation
as described above.
In experiments to test the ability of FTCD to promote Golgi–vimentin
association, Golgi elements isolated by upfloatation in a nycodenz gradi-
ent (see above) were first incubated with bacterially expressed and puri-
fied FTCD for 3 h at 4
 
8
 
C. BL21 (DE3) bacterial lysate without FTCD was
used in control incubations. The mixtures were adjusted to 1.6 M sucrose
(final concentration) in HKM and loaded on the bottom of centrifuge
tubes. The samples were overlaid with 1.3 and 0.8 M sucrose in HKM and
subjected to equilibrium centrifugation at 135,000 
 
g
 
 for 16 h in SW 50.1 ro-
tor at 4
 
8
 
C. Fractions were collected from the top, processed for SDS-
PAGE, and immunoblotted with anti-GM130 antibodies. GM130-con-
taining fractions were combined and incubated with vimentin for 3 h at
4
 
8
 
C. The mixtures were adjusted to 1.6 M sucrose final concentration and
loaded at bottoms of tubes, overlaid with 0.8 and 1.3 M sucrose in HKM,
and subjected to another round of equilibrium centrifugation as described
above. Fractions were collected and analyzed as described above.
 
Solid Phase Binding Assays: Binding of FTCD
to Vimentin
 
A 96-well RIA/EIA plate was coated with 1 mg/ml poly-
 
L
 
-lysine (Sigma-
Aldrich) in water (75 
 
m
 
l/well) for 20 min at room temperature. The plate
was washed with water, and 50 
 
m
 
l of buffer (10 mM Tris-HCl, pH 7.4) or
bacterially expressed and purified mouse vimentin at 20 
 
m
 
g/ml in the same
buffer was added to each well. Each experiment group was done in tripli-
cate. The plate was incubated at 32
 
8
 
C for 2 h and washed once with HK
(25 mM Hepes, 115 mM potassium acetate, pH 7.4). The plate was
blocked with 1% BSA–HK (100 
 
m
 
l/well) for 1 h at 32
 
8
 
C and then washed
with HK two times. Bacterially expressed and purified FTCD was first di-
luted to 3 
 
m
 
g/ml in 1% BSA–HK, and then supplemented with goat anti-
vimentin serum or with nonimmune goat serum (serum dilution was 1:15),
and the mixtures were added to wells. The plate was incubated for 2 h at
32
 
8
 
C and washed with HK (five times, 2 min each). The bound material
was recovered from each well with 50 
 
m
 
l SDS-PAGE sample buffer. Solu-
tions from the triplicate wells were pooled. Equal volume of samples from
each group was analyzed by immunoblotting using rabbit anti–pig FTCD
antibody. 
 
FTCD-mediated Binding of Golgi Elements to Vimentin
 
The plate was coated with poly-
 
L
 
-lysine, incubated with vimentin, and
blocked with BSA–HK as described above. Each experimental group had
four wells. Bacterially expressed and purified FTCD was diluted with 1%
BSA–HK to 3 or 1 
 
m
 
g/ml and added to the plate. Control group received
only 1% BSA–HK. The plate was incubated for 2 h at 32
 
8
 
C and washed
with HK four times. Isolated Golgi elements were diluted in 1% BSA–HK
to 80 
 
m
 
g/ml, and 50 
 
m
 
l was loaded per well. Control wells received only
1% BSA–HK. The plate was incubated at room temperature for 2 h and
washed with HK. All wells received 50 
 
m
 
l monoclonal antigiantin antibod-
ies diluted in 1% BSA–HK, and the plate was incubated for 1 h at room
temperature, washed, and further incubated with 50 
 
m
 
l of HRP-labeled
secondary anti–mouse antibody for 1 h at room temperature. After wash-
ing with HK four times, all wells received 50 
 
m
 
l of 1 mg/ml OPD substrate
(Pierce Chemical Co.). The color was developed for 20 min and then
stopped by adding 50 
 
m
 
l of H
 
2
 
SO
 
4
 
 to each well.
 
Results
 
FTCD Colocalizes with Golgi Elements and with 
Vimentin IFs
 
Prior immunofluorescence studies have shown that FTCD
(previously called the 58K protein) localizes to the Golgi
region in cultured cells from various species and tissue ori-
gin (Donaldson et al., 1990; Lippincott-Schwartz et al.,
1990; Vaisberg et al., 1996). In agreement, endogenous
FTCD colocalizes with the Golgi protein marker GM130
in COS-7 cells (Fig. 1 A). However, the level of colocaliza-
tion was not perfect, and FTCD signal extended beyond
the region labeled with anti-GM130 antibodies. This find-
ing agrees with the incomplete colocalization between
FTCD and Golgi markers in DU249 chicken hepatoma
cells (Hennig et al., 1998) and suggests that, in addition to
binding to the Golgi, FTCD also associates with other cel-
lular structures that lie close to, but do not perfectly over-
lap with, the Golgi stack. Since the cytoplasmic non-Golgi
FTCD staining appeared slightly filamentous, we exam-
ined FTCD distribution in NIH3T3 cells stably expressing
GFP-tagged vimentin. As shown in Fig. 1 B, FTCD was
detected in a typical Golgi pattern (arrows) and in fila-
mentous extensions where it colocalized with vimentin fil-
aments (arrowheads). Similarly, careful analysis of FTCD
and endogenous vimentin distribution in the periphery of
COS-7 cells showed that FTCD is localized along vimentin
filaments (Fig. 1 C, arrowheads). FTCD localization to the
Golgi and to vimentin IFs was also seen in other cultured
cells (data not shown), indicating the commonality of this
distribution.
The unexpected colocalization of FTCD with vimentin
filaments suggested that FTCD might interact directly or
indirectly with the vimentin IF cytoskeleton.
 
FTCD Binds Directly to Vimentin IFs
 
To test whether FTCD and vimentin associate, bacterially
expressed and purified FTCD (Fig. 2 A) was tested for its
ability to bind to polymerized recombinant vimentin fila-
ments in a centrifugation-based assay. Under the centrifu-
gation conditions used, vimentin filaments were recovered
exclusively in the pellet (data not shown). In contrast, bac-
terially expressed FTCD is soluble and is recovered exclu-
sively in the supernatant following centrifugation in the
absence of vimentin filaments (Fig. 2 B, lanes 5 and 6).
However, when vimentin filaments are added to FTCD (in
different FTCD/vimentin ratios), significant proportions
of FTCD bind to the filaments and are recovered in the
pellets (lanes 1–4). In this experiment, FTCD is detected
by immunoblotting since monomeric FTCD and vimentin
comigrate on SDS-PAGE. To ensure that the signal is
FTCD, a control incubation lacking FTCD was analyzed 
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and shows no signal (Fig. 2 B, lanes 7 and 8). To confirm
that FTCD binding to vimentin filaments is specific, and
does not represent trapping within the filament meshwork,
pelleting of BSA was tested as a control. As shown in a
Coomassie brilliant blue–stained gel in Fig. 2 C, BSA did
not pellet with the vimentin filaments.
To morphologically examine FTCD binding to vimen-
tin, polymerized vimentin filaments were incubated with
bacterially expressed and purified FTCD (FTCD used in
this and all of the following experiments is analogous to
that in Fig. 2 A) and analyzed by EM. As control, poly-
merized filaments without FTCD were analyzed. As
shown in Fig. 2 D, and previously described (Nikolic et al.,
1996), vimentin filaments appear as a loose meshwork of
 
z
 
10-nm smooth filaments after staining with uranyl ace-
tate. In contrast, vimentin filaments incubated with FTCD
appear bumpy, and are decorated with spherical structures
irregularly spaced along the filaments (Fig. 2 E). The
spherical structures in the boxed region are shown at
higher magnification in Fig. 2 F and have dimensions (
 
z
 
12
nm) consistent with the previously reported size of FTCD
octamers (Beaudet and Mackenzie, 1976). Significantly,
the addition of FTCD resulted in more compacted and
dense filamentous aggregates. Often, spherical FTCD
structures were observed in between two parallel fila-
ments (Fig. 2 G, arrows) or at intersections of filaments
(data not shown), suggesting that FTCD might bundle vi-
mentin filaments.
To confirm the FTCD-vimentin interaction, and to test
whether FTCD can bind to subunit vimentin, FTCD over-
lay assay was carried out. Bacterially expressed and puri-
fied FTCD, BSA, and recombinant vimentin were sub-
Figure 1. Endogenous FTCD localizes to Golgi elements and to vimentin IFs. (A) COS-7 cells were processed for immunofluorescence
using monoclonal anti-FTCD (FTCD) and polyclonal anti-GM130 (GM130) antibodies. FTCD colocalizes with the Golgi marker
GM130 but is also present in areas lacking GM130 (arrowheads). (B) NIH3T3 cells stably expressing GFP–vimentin were processed for
immunofluorescence using monoclonal anti-FTCD antibodies. FTCD localizes to Golgi elements (arrows) and to vimentin filaments
(arrowheads). (C) COS-7 cells were processed for immunofluorescence using polyclonal anti-FTCD and monoclonal anti-vimentin an-
tibodies. FTCD localizes to vimentin filaments in cell periphery (arrowheads). 
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jected to SDS-PAGE and are shown in a Coomassie blue–
stained gel in Fig. 2 I. An analogous gel was transferred to
NC membrane and overlaid with 
 
35
 
S-radiolabeled FTCD
generated in vitro by coupled transcription/translation
(Fig. 2 H). As shown in the fluorograph in Fig. 2 J, radiola-
beled FTCD preferentially bound to FTCD and vimentin.
Binding to FTCD was expected since FTCD homooli-
gomerizes to form the native octomeric structure (Find-
lay and MacKenzie, 1987). Quantitation of the relative
amounts of each protein in I and the relative amounts of
 
35
 
S-FTCD bound to each protein in J showed that 
 
z6-fold
more radiolabeled FTCD bound to FTCD than to BSA,
and z10-fold more radiolabeled FTCD bound to vimentin
than to BSA.
Figure 2. FTCD binds di-
rectly to vimentin IFs. (A)
FTCD expression was in-
duced by IPTG in bacteria,
and FTCD was purified as
described in Materials and
Methods. A Coomassie
blue–stained gel shows a ma-
jor 58-kD FTCD band (ar-
rowhead). (B) Bacterially ex-
pressed and purified FTCD
was mixed in different ratios
with polymerized vimentin
filaments and centrifuged at
100,000 g for 30 min at 208C.
The supernatants and pellets
were recovered, and an
equivalent proportion of
each was processed by SDS-
PAGE. The proteins were
transferred to NC and im-
munoblotted with poly-
clonal anti-FTCD antibod-
ies. FTCD remains soluble in
the absence of vimentin fila-
ments (lanes 5 and 6), but
pellets when vimentin fila-
ments are added (lanes 1 to
4). In lanes 7 and 8, only vi-
mentin without added FTCD
was processed. (C) BSA was
incubated with vimentin fila-
ments, and the mixture was
centrifuged as above. The su-
pernatant and pellet were re-
covered, and an equivalent
proportion of each was pro-
cessed by SDS-PAGE and
Coomassie blue staining.
BSA does not bind to and is
not recovered with vimentin
filaments. (D–G) Vimentin
filaments alone (Vimentin)
or incubated with bacterially
expressed and purified
FTCD (Vimentin 1 FTCD)
were stained with uranyl ace-
tate and visualized by EM. In
the vimentin only sample,
the filaments appear smooth
(D), whereas filaments incu-
bated with FTCD are decorated with spherical structures (E). A higher magnification of the area in E, is shown in F. The size of the
spherical structures is z12 nm (arrows) and is consistent with the size of FTCD octomers. The spherical structures were often seen link-
ing individual vimentin filaments (G, arrows). (H) rFTCD–pBS was used as template in an in vitro transcription/translation reaction. A
fluorograph of generated products shows a major 58-kD protein (arrowhead). (I) Bacterially expressed and purified FTCD, BSA and
bacterially expressed and purified mouse vimentin were processed by SDS-PAGE, and the gel stained with Coomassie blue to show rel-
ative amounts of proteins. (J) A gel analogous to that in I was transferred to NC and overlaid with 35S-FTCD, as generated in H. Radi-
olabeled FTCD binds directly and specifically to FTCD and vimentin. Bar, 100 nm.Gao and Sztul Golgi Complexes Interact with Vimentin IF Cytoskeleton 883
The biochemical and morphological data document the
novel association of FTCD with vimentin subunits and with
assembled vimentin filaments. Together, our results show
that FTCD interacts with the Golgi complex and with the
vimentin IF cytoskeleton, suggesting that FTCD might par-
ticipate in these cellular components.
FTCD Mediates Remodelling of the Vimentin
IF Cytoskeleton
To initiate the inquiry into the intracellular function of
FTCD, we transiently expressed GFP-tagged and -untagged
full-length FTCD in COS-7 cells. As shown in Fig. 3 A, in
cells expressing low levels of GFP–FTCD, the recombinant
protein was predominantly localized to the Golgi area,
where it colocalized with GM130. In addition, faint filamen-
tous staining extending from the Golgi region in a pattern
similar to that of endogenous FTCD was detected. The
faithfulness of GFP–FTCD distribution was also analyzed
by fractionation after cell disruption. As shown in Fig. 3 D,
the distribution of GFP–FTCD paralleled that of endoge-
nous FTCD. Both were predominantly recovered at the
bottom of the gradient (fractions 9–15), representing the
high density sucrose load and containing soluble cytosolic
proteins. Only a small amount of GFP–FTCD and endoge-
nous FTCD was recovered in the low density sucrose (frac-
tions 5–7) enriched in the Golgi membrane marker GM130.
These results are analogous to those seen following homog-
enization of rat liver, where FTCD was predominantly
found in the cytosolic fraction, with only a small proportion
(,10%) cofractionating with Golgi membranes (Bloom
and Brashear, 1989; Gao et al., 1998).
To ensure that the observed distribution of GFP–FTCD
was not influenced by the GFP part of the chimera, un-
tagged FTCD was expressed in COS-7 cells, and its local-
ization was detected with anti-FTCD antibodies. In this
and all other experiments involving recombinant FTCD
transfections, anti-FTCD antibodies were used at a high di-
lution adjusted to detect only the recombinant but not the
Figure 3. FTCD targets to the Golgi
complex and organelles into fibers.
COS-7 cells were transfected with
GFP-tagged (A) or -untagged (B and
C) rFTCD and grown for 18–48 h. (A)
Cells were processed for immunofluo-
rescence with polyclonal anti-GM130
antibodies. (B and C) Cells were pro-
cessed for immunofluorescence with
monoclonal anti-FTCD and poly-
clonal anti-GM130 antibodies. In cells
expressing low levels of FTCD (A and
B), the recombinant FTCD is concen-
trated in the Golgi region. In cells ex-
pressing high levels of FTCD (C), the
recombinant FTCD also localizes to
thick fibers originating from the Golgi
region. (D) COS-7 cells were trans-
fected with GFP–FTCD for 48 h and
fractionated by equilibrium density
centrifugation. An equivalent amount
of each fraction was processed by SDS-
PAGE, transferred to NC, and immu-
noblotted with anti-FTCD antibodies
to detect the 58-kD endogenous FTCD
and the 86-kD recombinant GFP–
FTCD. The NC was also probed with
anti-GM130 antibodies. The relative
recovery of endogenous FTCD, GFP–
FTCD, and GM130 in each lane were
quantitatively evaluated by densitome-
try. Endogenous FTCD and GFP–
FTCD were predominantly recovered
in the high density sucrose load (frac-
tions 9–15) containing soluble cytosolic
proteins. A proportion of FTCD and
GFP–FTCD were recovered in low
density sucrose (fractions 5–7) en-
riched in the Golgi marker GM130.The Journal of Cell Biology, Volume 152, 2001 884
endogenous FTCD. As shown in Fig. 3 B, in cells express-
ing low levels of FTCD, the recombinant protein predomi-
nantly localized to GM130-containing Golgi elements and
to adjacent filamentous structures. The distribution was in-
distinguishable from that of endogenous FTCD and GFP-
tagged FTCD. A different pattern was observed in cells ex-
pressing higher levels of recombinant FTCD, where fila-
mentous structures originating from the Golgi region were
significantly more pronounced (Fig. 3 C). In addition, the
fibers appeared thicker and more disorganized. Based on
the finding that FTCD interacts directly with vimentin fila-
ments, we examined if the thick filamentous structures
contain vimentin.
As shown in Fig. 4 A, in COS-7 cells expressing high lev-
els of FTCD, dramatic processes positive for FTCD and
for vimentin were apparent. This pattern was observed in
many cells, and quantitation of cells 48 h after transfection
showed that z70% of transfected cells contained exten-
sive FTCD fibers. The FTCD fibers originated from the
peri-Golgi region and radiated outwards towards the cell
periphery. Exact colocalization of FTCD and vimentin
was observed in all fibers. In all cases, vimentin IFs were
disfigured to a different extent, from mild thickening of
the normally delicate filaments to the formation of very
thick bundles. In the latter case, most of the cellular vi-
mentin appeared integrated into the bundles, resulting in a
marked depletion of vimentin filaments from the cell pe-
riphery (dash lines mark the border of a transfected cell in
Fig. 4 A). To ensure that the formation of the FTCD/vi-
mentin fibers was not an artifact of expressing rat FTCD
in a particular simian COS-7 background, we transfected
the rat FTCD construct into various mammalian cells.
Analogous fibrillar FTCD/vimentin structures were seen
in transfected human, rat, and mouse cells (Figs. 4 E and 5
B; and data not shown).
Together, the data indicate that FTCD interacts with
and drastically modulates the structure of the vimentin IF
cytoskeleton.
FTCD-mediated Remodelling of the Vimentin IF 
Cytoskeleton Does Not Involve Changes in the Actin or 
the Microtubule Cytoskeletons
The IF cytoskeleton physically and functionally interacts
with the two other cellular cytoskeletons composed of ac-
Figure 4. FTCD remodels the vimentin IF cytoskeleton independent of the actin and the microtubule cytoskeletons. COS-7 cells (A–D)
or NRK cells (E) were transfected with rFTCD–pcDNA, grown for 48 h, and processed for immunofluorescence. (A) Cells were la-
beled with polyclonal anti-FTCD and monoclonal antivimentin antibodies. The border of a transfected cell is outlined by dashed lines.
The vimentin cytoskeleton is perturbed in the transfected cell colocalizes with vimentin to thick fibers originating from the Golgi region.
(B) Cells were labeled with polyclonal anti-FTCD antibodies and phalloidin–FITC. Actin distribution in the transfected cell is indistin-
guishable from that in untransfected cells. (C) Cells were labeled with polyclonal anti-FTCD and monoclonal anti–b-tubulin antibodies.
The microtubule pattern in transfected cells is indistinguishable from that in untransfected cells. (D) Cells were treated with 10 mg/ml
nocodazole for 3 h at 378C, then labeled with polyclonal anti-FTCD and monoclonal anti–b-tubulin antibodies. FTCD fibers persist de-
spite the disruption of the microtubular network. (E) Cells were treated with 10 mg/ml nocodazole for 3 h at 378C, and then labeled with
polyclonal anti-FTCD and monoclonal antivimentin antibodies. FTCD/vimentin fibers persist despite the disruption of the microtubu-
lar network.Gao and Sztul Golgi Complexes Interact with Vimentin IF Cytoskeleton 885
tin filaments and microtubules (Blose et al., 1984; Svitkina
et al., 1996; Yang et al., 1996, 1999; Liao and Gundersen,
1998; Prahlad et al., 1998; Correia et al., 1999). The IF ar-
chitecture appears to be at least partially regulated by the
other cytoskeletal systems, as shown, for example, by the
coordinate collapse of IFs following the disruption of
the microtubule cytoskeleton by drug treatments or by in-
jection of antitubulin and antikinesin antibodies (Blose et
al., 1984; Gyoeva and Gelfand, 1991; Svitkina et al., 1996).
Therefore, we examined whether the observed changes in
vimentin IFs could be due to effects of FTCD overexpres-
sion on the actin and/or the microtubule cytoskeleton. As
shown in Fig. 4 B, cells expressing recombinant FTCD
contained normal cortical actin and actin cables and stress
fibers, indistinguishable from those in the neighboring un-
transfected cells. Furthermore, the FTCD fibers did not
colocalize with actin-containing structures, suggesting that
the remodelling of the IF cytoskeleton has no marked ef-
fect on the integrity of the actin cytoskeleton. In agree-
ment, rFTCD–pcDNA-transfected cells showed no change
in cell shape or ability to adhere to the substrate.
Similarly, the microtubule cytoskeleton of a rFTCD–
pcDNA-transfected cell is not visibly altered from that
seen in adjacent untransfected cells (Fig. 4 C). Microtu-
bule distribution was largely undisturbed even in cells
where drastic rearrangement of IFs had occurred. FTCD
fibers and microtubules often appeared in close juxtaposi-
tion, paralleling but not exactly colocalizing with each
other. Because of this close apposition and the previously
described microtubule-dependent kinesin-based extension
of peripheral IFs (Gyoeva and Gelfand, 1991; Liao and
Gundersen, 1998; Kreitzer et al., 1999), we explored
whether the maintenance of the FTCD/vimentin fibers
was dependent on the presence of an intact microtubule
cytoskeleton. Cells were treated with the microtubule de-
polymerizing drug nocodazole, and the fate of microtu-
bules and the FTCD fibers was monitored by double label
immunofluorescence. As shown in Fig. 4, D and E, FTCD/
vimentin fibers persisted in the nocodazole-treated cells,
despite the complete disruption of the microtubule cyto-
skeleton. These results indicate that assembled FTCD/
vimentin fibers are relatively stable, and their mainte-
nance is independent of the microtubule cytoskeleton. Sim-
ilarly, microtubules were not stabilized by the FTCD/
vimentin fibers. Together, the data indicate that FTCD ex-
erts its effects on the vimentin IF cytoskeleton directly, with-
out disrupting the actin or the microtubule cytoskeletons.
FTCD Mediates Fiber Formation Only in the Presence 
of Cellular Vimentin
The colocalization of FTCD and vimentin in the fibers
could represent an independent assembly of FTCD and vi-
mentin into filaments and a subsequent linking to form
chimeric fibers. To explore whether the formation of the
FTCD fibers can occur independently of vimentin or is
obligatorily coupled to the coassembly of vimentin into
the same structure, a vimentin-minus (vim2/2) cell line
(MFT-16) derived from a vimentin knockout mouse
(Colucci-Guyon et al., 1994; Svitkina et al., 1996; Holwell
et al., 1997) was transfected with rFTCD–pcDNA, and the
distribution of recombinant FTCD was analyzed. As a
control, a vimentin-plus (vim1) cell line (MFT-6) derived
from a normal litter mate of the knockout mouse was sim-
ilarly analyzed. As shown in Fig. 5 A, recombinant FTCD
appeared uniformly distributed throughout the cytoplasm
and did not form fibers in the MFT-16 (vim2/2) cells. In
contrast, extensive fibers were visible in the MFT-6 (vim1)
control cell line (Fig. 5 B). The overall morphology of the
FTCD/vimentin fibers in the MFT-6 cells was indistin-
guishable from those in COS-7 or NRK cells. These results
indicate that the formation of the fibrous structures of
FTCD is intrinsically dependent on the presence of vimen-
tin, suggesting that FTCD and vimentin coassemble into
the chimeric fibers.
FTCD Mediates Coordinate Rearrangement of 
Vimentin IFs and Golgi Structure
We have shown that FTCD interacts with the Golgi and
binds to vimentin IFs, suggesting that the formation of
FTCD/vimentin fibers might influence Golgi structure.
To examine this, COS-7 cells were transfected with
FTCD or GFP–FTCD to induce formation of fibers, and
then Golgi structure was analyzed. A transfected cell
containing numerous FTCD/vimentin fibers radiating
from the perinuclear MTOC region is shown in Fig. 6 A.
The overall Golgi morphology in the transfected cell is
relatively normal compared with that seen in a neighbor-
ing untransfected cell, except for a tubular extension (ar-
rowhead) projecting from the otherwise compact Golgi
Figure 5. FTCD fiber formation requires vimentin IFs. MFT-16
cells derived from a vimentin knockout mouse and lacking vimen-
tin (vim2/2) and MFT-6 cells derived from a normal litter mate
and containing vimentin (vim1) were transfected with rFTCD–
pcDNA. 48 h later, cells were processed for immunofluorescence
using polyclonal anti-FTCD and monoclonal antivimentin anti-
bodies. FTCD/vimentin fibers form only in the vim1 cells,
whereas FTCD remains diffusely distributed in the vim2/2 cells.The Journal of Cell Biology, Volume 152, 2001 886
complex. The Golgi extension appears aligned along one
of the FTCD/vimentin fibers and precisely colocalizes
with it. Such Golgi extensions were rarely observed in
cells without FTCD/vimentin fibers. The unusual exten-
sions of Golgi elements were also seen in cells containing
GFP–FTCD/vimentin fibers (Fig. 6 B). In all cases, the
Golgi tubules originated from the perinuclear MTOC re-
gion and were associated with the GFP–FTCD/vimentin
fibers. The Golgi extensions were either continuous or,
as shown in this cell, fragmented into individual elements
(arrowhead). Significantly, all Golgi fragments were
aligned on the FTCD/vimentin fiber. The Golgi fragmen-
tation was often extreme, and many cells containing
GFP–FTCD/vimentin fibers exhibited dramatic Golgi re-
arrangements (Fig. 6 C). The Golgi complex was no
longer a single compact structure but appeared as an as-
Figure 6. FTCD mediates coordinate
disruption of vimentin IF cytoskele-
ton and Golgi structure. COS-7 cells
were transfected with untagged (A)
or GFP-tagged (B and C) FTCD. 48 h
later, cells were processed for immuno-
fluorescence using monoclonal anti-
FTCD and polyclonal anti-GM130
antibodies (A) or only polyclonal
anti-GM130 antibodies (B and C).
Numerous FTCD/vimentin fibers
originating from the Golgi region are
evident in the transfected cells. The
structure of the Golgi complex is per-
turbed to a varying degree in trans-
fected cells, from a relatively normal
Golgi complex containing a single tu-
bular protrusion (arrowhead in A), to
a Golgi complex with a projection
fragmented into individual elements
(arrowhead in B), to a completely dis-
persed Golgi structure (arrowheads in
C). In all cases, the fragmented Golgi
elements are associated with the
FTCD/vimentin fibers.Gao and Sztul Golgi Complexes Interact with Vimentin IF Cytoskeleton 887
sembly of smaller punctate or tubular elements. A pro-
portion of the Golgi fragments were localized to the
perinuclear MTOC region, but many were in more pe-
ripheral regions of cells. However, all of the Golgi ele-
ments were associated with the GFP–FTCD/vimentin fil-
aments (arrowheads).
Our results that FTCD interacts with the Golgi complex
and with vimentin IFs, and that it coordinately influences
the structure of the Golgi and the vimentin IF cytoskele-
ton, raised the possibility that the Golgi complex and the
vimentin IF cytoskeleton might interact, and that FTCD
might participate in this interaction.
Figure 7. Golgi elements interact with vimentin filaments in vivo. (A) MFT-6 cells were labeled with polyclonal anti-GM130 and mono-
clonal antivimentin antibodies. Extended Golgi elements align with vimentin filaments (arrowheads). (B) MFT-6 cells were treated
with 10 mg/ml nocodazole for 5 h at 378C before labeling as in A. The Golgi complex was disrupted into Golgi ministacks, but the Golgi
ministacks were associated with vimentin filaments (arrowheads). Arrow points to a mass of collapsed vimentin. (C) NRK cells were
treated with 10 mg/ml nocodazole for 5 h at 378C and then labeled with polyclonal anti-GM130 and monoclonal anti-FTCD antibodies.
FTCD colocalizes with GM130 in Golgi ministacks (arrowheads).The Journal of Cell Biology, Volume 152, 2001 888
Golgi Elements Associate with Vimentin IFs
To test whether Golgi elements and vimentin filaments as-
sociate in vivo, we examined mouse MFT-6 cells processed
for double label immunofluorescence to detect the Golgi
protein GM130 and vimentin. As shown in Fig. 7 A, MFT-
6 cells have relatively large and extended Golgi com-
plexes, with individual Golgi elements often colocalizing
with vimentin IFs (arrowheads). Careful examination of
distinct focal planes indicated that the majority of Golgi
ribbons are closely aligned and parallel the vimentin fila-
ments. Analogous images were observed in COS-7, NRK,
and HeLa cells (data not shown), showing the generality
of the Golgi–vimentin IFs association.
The observed colocalization could reflect the association
of Golgi elements with microtubules, since microtubules
and IFs have been previously reported to be in a parallel
arrangement (Gurland and Gundersen, 1995). Therefore,
to examine whether Golgi elements associate with IFs in-
dependent of microtubules, we disrupted microtubules
with nocodazole and then reexamined the localization of
Golgi elements and vimentin IFs. Golgi morphology and
localization near the MTOC is dependent on intact micro-
tubules (Rogalski and Singer, 1984), and disruption of mi-
crotubules results in the appearance of scattered punctate
structures shown to represent Golgi ministacks (Cole et
al., 1996). As shown in Fig. 7 B, in nocodazole-treated
MFT-6 cells, the Golgi complex is dispersed into scattered
punctate structures. Significantly, these structures are asso-
ciated with vimentin filaments traversing the cells (arrow-
heads). Quantitation indicated that z80% of the counted
1,032 Golgi ministacks were directly on vimentin fila-
ments. This is likely to be an underestimate since some of
the thin IFs might be out of the plane of focus and difficult
to detect. Analysis of analogous sections with antitubulin
antibodies indicated absence of intact microtubules (data
not shown; and Fig. 4 D).
The morphologically observed association was con-
firmed biochemically, using a centrifugation-based Golgi–
vimentin binding assay. The Golgi fraction used in this and
subsequent studies is isolated from rat liver homogenate
and is enriched in SG complexes as described previously
(Salamero et al., 1990). Recombinant vimentin remained in
high density sucrose fractions when loaded on the bottom
of a discontinuous sucrose gradient and subjected to cen-
trifugation in the absence of Golgi elements (Fig. 8 A, vi-
mentin only, fractions 5–11). In contrast, when recombi-
nant vimentin was incubated with isolated Golgi elements
and the mixture was subjected to centrifugation, a propor-
tion of vimentin was detected in lower density sucrose frac-
tions (vimentin 1 Golgi, vimentin). These fractions contain
Golgi elements as shown by enrichment in GM130 (vimen-
tin 1 Golgi, GM130). To ensure that the vimentin recov-
ered in the lower density fractions is membrane bound and
does not represent contamination with soluble vimentin,
fractions 3 and 4 from A were combined, loaded on the
bottom of a discontinuous sucrose gradient, and subjected
to another round of centrifugation. As shown in Fig. 8 B,
vimentin was predominantly recovered in lower density
fractions and was minimally recovered in the high density
load fractions (vimentin). The lower density fractions con-
tained Golgi elements as shown by their content of GM130
(GM130). It should be noted that within the sensitivity lim-
its of our immunoblotting assay, the isolated Golgi fraction
does not contain detectable vimentin (data not shown),
suggesting that the vimentin recovered in the light density
fractions bound to Golgi elements during the incubation.
Together, the morphological and biochemical results
document the previously unrecognized association be-
tween Golgi elements and vimentin IFs.
FTCD Promotes Association between Golgi Elements 
and Vimentin IFs
The association of Golgi ministacks with vimentin fila-
ments in vivo, and the binding of Golgi elements and vi-
mentin in vitro, implies the presence of specific proteins
that mediate the interaction. Since FTCD binds to Golgi
elements and vimentin, it might serve as a linking compo-
nent. In agreement, FTCD colocalizes with Golgi minis-
tacks aligned on vimentin filaments after microtubule dis-
ruption (Fig. 7 C, arrowheads), consistent with the putative
role of FTCD in tethering Golgi elements and IFs.
To explore the possible linking function of FTCD, we
first tested whether FTCD can promote Golgi–vimentin
interactions using a density gradient centrifugation assay.
Isolated Golgi elements were supplemented either with
bacterially expressed and purified FTCD or with control
bacterial lysate without FTCD, loaded at the bottom of a
sucrose density gradient, and centrifuged. Upfloated
membranes from each group were incubated with vimen-
tin and subjected to another round of equilibrium centrifu-
gation. The fractions were collected and tested for their
content of vimentin, GM130, and FTCD. As shown in Fig.
9 A, when Golgi elements are not preincubated with
FTCD (SG 1 control lysate 1 vimentin), vimentin is pre-
dominantly recovered in the load at the bottom of the gra-
dient (fractions 5–11), with small amount recovered in
lower density fractions containing the bulk of the Golgi
marker GM130 (fractions 2 and 3). A significantly differ-
ent vimentin distribution pattern is obtained when Golgi
elements are preincubated with FTCD. As shown in Fig. 9
A, in the presence of exogenous FTCD (SG 1 FTCD 1
Figure 8. Golgi elements in-
teract with vimentin fila-
ments in vitro. (A) Recom-
binant vimentin alone
(Vimentin only) or recombi-
nant vimentin incubated with
isolated Golgi elements (Vi-
mentin 1 Golgi) were loaded
at the bottom of a sucrose
density gradient and sub-
jected to equilibrium centrif-
ugation. An equivalent
amount of each fraction was
processed by SDS-PAGE,
transferred to NC, and im-
munoblotted with antivimentin and anti-GM130 antibodies. Vi-
mentin remains in the load when centrifuged alone but is recov-
ered in a lower density fraction containing the Golgi marker
GM130 when incubated with Golgi elements. (B) Fractions 3 and
4 from A were combined, loaded at the bottom of a sucrose den-
sity gradient, and subjected to another round of equilibrium cen-
trifugation. Fractions were collected and analysed as in A. Vi-
mentin remains associated with Golgi elements. Gao and Sztul Golgi Complexes Interact with Vimentin IF Cytoskeleton 889
vimentin), a significantly larger proportion of vimentin is
recovered in the Golgi containing fractions. Vimentin is
most enriched in fraction 3, which contains the bulk of
Golgi elements and the bulk of bound FTCD. These data
suggest that addition of FTCD promotes the association
between Golgi elements and vimentin.
These results were confirmed and extended using a solid
phase binding assay. To set up the assay, we tested param-
eters of recombinant FTCD binding to microtiter wells
containing or lacking adsorbed vimentin. As shown in Fig.
9 B, significant amounts of FTCD bound to microtiter
wells coated with vimentin, but minimal FTCD bound to
wells without vimentin, suggesting that FTCD binds to
the wells through interacting with vimentin. This was fur-
ther confirmed by the finding that addition of antivimentin
antibodies (to mask binding sites on vimentin) inhibited
FTCD binding, whereas addition of nonimmune antibod-
ies had no effect on FTCD binding. The results indicate
that FTCD binds specifically to vimentin immobilized in
microtiter wells, and that this assay can be used to test
whether vimentin-bound FTCD promotes binding of
Golgi elements.
First, we tested the binding of Golgi elements to microti-
ter wells in the absence of vimentin or FTCD. Basal level of
binding was observed (Fig. 9 C), and this represents the
background in this analysis. Increased binding of Golgi ele-
ments was observed when microtiter wells containing ad-
sorbed vimentin were tested, most likely reflecting binding
through intrinsic elements on the Golgi membrane. This
finding is in agreement with data presented in Fig. 8 A,
showing that vimentin and Golgi elements interact in a cen-
trifugation-based assay. Significantly, adding recombinant
FTCD to the vimentin-containing wells before adding Golgi
elements led to a dose-dependent (.130% at 1 mg/ml
FTCD and .160% at 3.5 mg/ml FTCD) increase in Golgi
elements binding. Together, the data indicate that FTCD
promotes binding between Golgi elements and vimentin.
Discussion
Structural and functional interactions between the Golgi
complex and the microtubule and the actin cytoskeletal
systems have been documented. The structure of the Golgi
complex and its localization adjacent to the MTOC is de-
pendent on intact microtubules since disruption of the mi-
crotubule cytoskeleton leads to fragmentation of the
single Golgi complex into numerous Golgi ministacks
scattered throughout the cell (reviewed in Kreis, 1990;
Cole et al., 1996). Although the interaction of Golgi ele-
ments with the actin cytoskeleton is less understood, com-
ponents of the actin-associated cytoskeleton such as a
b-spectrin isoform (Beck et al., 1994) and ankyrin iso-
forms (Devarajan et al., 1996; Holleran et al., 1996) have
Figure 9. FTCD promotes binding of Golgi elements to vimen-
tin. (A) Isolated Golgi elements were incubated either with bac-
terially expressed and purified FTCD (SG 1 FTCD 1 vimentin)
or with control bacterial lysate (SG 1 control lysate 1 vimentin).
The mixtures were loaded at the bottom of a sucrose density gra-
dient and subjected to equilibrium centrifugation to separate sol-
uble proteins from the Golgi membranes. Membrane-containing
fractions were combined and supplemented with recombinant vi-
mentin. The mixtures were loaded at the bottom of a sucrose
density gradient and subjected to another equilibrium centrifuga-
tion. An equivalent amount of each fraction was processed by
SDS-PAGE, transferred to NC, and immunoblotted with antivi-
mentin, anti-GM130, and anti-FTCD antibodies. A proportion of
vimentin binds to Golgi elements in the absence of exogenously
added FTCD (SG 1 control lysate 1 vimentin), but vimentin
binding is significantly increased by preincubating the Golgi ele-
ments with FTCD (SG 1 FTCD 1 vimentin). (B) Poly-L-lysine–
coated microtiter wells containing adsorbed vimentin (1) or
lacking vimentin (2) received bacterially expressed and purified
FTCD, a mixture of FTCD and goat antivimentin antiserum, or a
mixture of FTCD and goat nonimmune antiserum. After wash-
ing, bound material from triplicate wells was recovered with
SDS-PAGE sample buffer and pooled. The pooled material was
processed by SDS-PAGE, transferred to NC, and immunoblot-
ted with anti-FTCD antibodies. Vimentin mediates FTCD bind-
ing to the wells since FTCD is recovered in wells containing ad-
sorbed vimentin but not in wells lacking vimentin, and FTCD
binding is inhibited by antivimentin antibodies. (C) Poly-
L-lysine–coated microtiter wells lacking vimentin or containing
adsorbed vimentin received buffer, or increasing amounts of bac-
terially expressed and purified FTCD. Each experimental group
contained four wells. After washing to remove unbound FTCD,
isolated Golgi elements were added to the wells. After washing
to remove unbound Golgi elements, antigiantin antibodies and
HRP-conjugated secondary antibodies were added sequentially,
followed by an HRP-based colorimetric assay. Background value
without Golgi addition has been subtracted from each group. The
amount of Golgi binding to vimentin-containing wells without
FTCD was set as 1. Each value is an average of three indepen-
dent experiments, and bars indicate SD. Golgi elements prefer-
entially bind to wells containing adsorbed vimentin, and this as-
sociation is increased by FTCD in a dose-dependent manner.The Journal of Cell Biology, Volume 152, 2001 890
been shown to preferentially localize to the Golgi com-
plex, suggesting a link.
Interactions between the Golgi complex and the IF cy-
toskeleton have not been extensively studied. Here, we
document the novel association of Golgi elements with vi-
mentin filaments and show that the peripherally associ-
ated Golgi protein FTCD directly interacts with vimentin
filaments and can coordinately remodel the vimentin IF
cytoskeleton and the Golgi complex. Our results suggest
that Golgi elements interface with the IF cytoskeleton and
that FTCD participates in coupling Golgi membranes to
vimentin filaments.
Golgi Ribbons and Golgi Ministacks Associate with 
Vimentin Filaments
It has been shown by stereo EM and computer graphic re-
construction that vimentin filaments and microtubules are
abundant in close vicinity to the Golgi complex, and some
appear intimately associated with the Golgi membrane
(Katsumoto et al., 1991). The close alignment between IFs
and the Golgi complex was also seen by scanning EM (Ta-
kumida and Anniko, 1994; Takumida and Anniko, 1996).
However, since IFs and microtubules often parallel each
other (Blose et al., 1984; Gurland and Gundersen, 1995),
the alignment between Golgi elements and IFs could re-
flect Golgi association with microtubules rather than IFs.
We explored whether Golgi complexes directly interact
with IFs by examining Golgi localization in cells lacking an
intact microtubule cytoskeleton and containing numerous
Golgi ministacks scattered throughout the cell (Cole et al.,
1996). Significantly, the Golgi ministacks were associated
with vimentin filaments, suggesting that Golgi elements in-
teract with vimentin filaments independently of the micro-
tubule cytoskeleton.
What might be the significance of linking Golgi ele-
ments to the vimentin cytoskeleton? It is clear that Golgi
structure and function are not fundamentally dependent
on the vimentin IFs since, in vim2/2 MFT-16 cells, the
Golgi complexes appear normal (data not shown), and the
vimentin knockout mouse appears to maintain normal
secretory functions (Colucci-Guyon et al., 1994). How-
ever, as shown here, rearrangement of the vimentin IF cy-
toskeleton is paralleled by changes in Golgi structure, sug-
gesting that the Golgi complex and the IF cytoskeleton are
linked and that a hierarchy of interactions involving all
three cytoskeletal systems might modulate Golgi structure
and function in vivo. The microtubule cytoskeleton ap-
pears most important since perturbations cause complete
disruption of Golgi structure and significant decrease in
secretory function (Rogalski and Singer, 1984). More sub-
tle defects are seen when Golgi interactions with the actin
cytoskeleton are perturbed: in cells in which dominant
negative mutants of Golgi-specific spectrin isoforms are
expressed, the Golgi structure remains relatively normal,
but the trafficking of the a and the b subunits of Na,
K-ATPase, and the VSV-G protein through the Golgi
seems impaired (Devarajan et al., 1997). It is likely that
linking Golgi elements to vimentin IFs is also required for
the more subtle functions of the organelle. For example,
studies examining glycolipid synthesis have documented
that, in vim2/2 cells, the intracellular transport of glycolipids
between the endosomal/lysosomal pathway and the Golgi
complex appears impaired (Gillard et al., 1998). Thus, in-
teractions between the Golgi and the IFs might integrate
the secretory pathway with the IF cytoskeleton, conse-
quently coordinating the efficiency and fidelity of mem-
brane traffic with the motility, adhesion, and/or polarity
status of the cell.
FTCD Represents a Novel Type of Golgi
Complex–associated IFAP
We consider the peripherally associated Golgi protein
FTCD an IFAP since it binds directly to vimentin subunits
and to polymerized vimentin, integrates into vimentin-
based filaments, and dramatically changes the structure of
the vimentin IF cytoskeleton.
The most extensively studied IFAPs are those belonging
to a related family of plakins characterized by a conserved
overall structure and partial sequence homology. Plectin
mediates the interaction of vimentin IFs with actin- and
microtubule-based filaments, as well as with specialized
membrane adhesion zones (Foisner et al., 1995; Svitkina et
al., 1996). A related protein, filamin, links vimentin IFs
only to actin filaments (Brown and Binder, 1992), whereas
the desmosomal plague component, desmoplakin, might
link vimentin IFs to the adhesion zone (Stappenbeck and
Green, 1992; Stappenbeck et al., 1993). In addition to
plakins, other proteins also interact with vimentin. Specific
kinases, including PKC b (Murti et al., 1992; Spudich et al.,
1992) and PKC e isoforms (Owen et al., 1996), cGMP ki-
nase (Pryzwansky et al., 1995), and Yes kinase (Ciesielski-
Treska et al., 1995), a nucleoside diphosphate kinase
(Otero, 1997), a transglutaminase (Trejo-Skalli et al., 1995;
Clement et al., 1998), proteins related to the small heat
shock protein family, a-crystallins (Nicholl and Quinlan,
1994; Perng et al., 1999), and the actin-binding protein fim-
brin (Correia et al., 1999), bind to vimentin and might par-
ticipate in modulating the organization or the dynamics of
IF assembly. Based on the structural heterogeneity of vari-
ous vimentin-binding proteins, it is likely that a spatially
relevant conformation might mediate vimentin binding or
that many distinct binding motifs can be used. The molec-
ular basis of FTCD interaction with vimentin is not obvi-
ous, based on its primary structure, since FTCD has no se-
quence homology with any previously characterized IFAP.
FTCD participation in vimentin-based events was unex-
pected since FTCD has been studied predominantly as a bi-
functional enzyme involved in the degradation of histidine
(MacKenzie et al., 1980). The two enzymatic activities of
FTCD reside in a single polypeptide chain, with the trans-
ferase domain at the NH2-terminal region, connected by a
short region to the deaminase domain at the COOH termi-
nus (Murley and MacKenzie, 1995). Dimerization is re-
quired for each monofunctional activity, but the overall en-
zymatic property of FTCD is further regulated by its
assembly into a planar octamer (Beaudet and MacKenzie,
1976; MacKenzie et al., 1980; Findlay and MacKenzie,
1987, 1988). Although the involvement of a FTCD in regu-
lating vimentin filament dynamics was unexpected, it has a
precedent: mutations in the enzyme superoxide dismutase
have been shown to cause accumulation of neurofilaments
in neurons and result in amyotrophic lateral sclerosis (for
review see Cleveland, 1999). This effect was not dependent
on the enzymatic activity of the protein, suggesting that su-
peroxide dismutase performs other cellular functions rele-
vant for neurofilament dynamics. Similarly, FTCD mightGao and Sztul Golgi Complexes Interact with Vimentin IF Cytoskeleton 891
perform multiple cellular functions, including participation
in the organization and/or assembly of the vimentin IF cy-
toskeleton.
FTCD Influences the Structure of the Vimentin
IF Cytoskeleton
Normally, the vimentin IF cytoskeleton consists of anasto-
mosing arrays of fibers, usually concentrated around the
nucleus and the peri-Golgi region and extending in irregu-
lar networks towards the cell periphery. In FTCD express-
ing cells, thick FTCD/vimentin fibers originate from the
peri-Golgi region and either extend towards the periphery
or coil around the nucleus and cell core. Formation of the
fibers is concurrent with significant depletion of peripheral
vimentin elements. The changes in the IF cytoskeleton are
not secondary effects caused by alterations in the actin or
microtubule cytoskeletons, since these networks appear
unperturbed by FTCD expression. The lack of microtu-
bule disruption was especially relevant since the FTCD ef-
fect superficially resembled the pattern seen in cells in
which the microtubule cytoskeleton was collapsed by de-
polymerization of microtubules (Gurland and Gundersen,
1995) or interference with kinesin, a microtubule-based
motor protein shown to mediate peripheral extension of
vimentin IFs on microtubules (Gyoeva and Gelfand, 1991;
Liao and Gundersen, 1998). These results imply that, in
FTCD-transfected cells, the interactions of IFAPs that
normally cross-link IFs to actin or microtubule systems is
severed. Whether this is accomplished by FTCD displac-
ing the IFAPs from the vimentin binding sites, or by other
events, remains to be investigated and will provide mecha-
nistic insight into how different IFAPs, including FTCD,
control vimentin IF dynamics. The aberrant FTCD/vimen-
tin fibers are also not novel forms of aggresome, a struc-
ture that appears to recruit vimentin filaments to its sur-
face (data not show; Garcia-Mata et al., 1999; Johnston et
al., 1998).
The formation of thick FTCD/vimentin fibers in vivo
and the ability of recombinant FTCD to bridge vimentin
filaments in vitro suggest that FTCD mediates cross-link-
ing of vimentin filaments into higher order structures. In
agreement, we observed that expression of FTCD causes
bundling of individual FTCD/vimentin fibers when im-
aged in real time in vivo (data not shown). The cross-link-
ing function of FTCD is consistent with its oligomeric
structure, planar shape, and size. The FTCD bagel-like
ring of eight identical subunits is arranged as a tetramer of
dimers. If each FTCD dimer interacts with a different vi-
mentin filament simultaneously, the octamer could cross-
link four vimentin filaments. Negative staining EM of na-
tive FTCD shows an z12-nm-diam ring (Beaudet and
MacKenzie, 1976; MacKenzie et al., 1980), and these di-
mensions are theoretically large enough to cross-link four
individual 10-nm vimentin filaments.
FTCD Integrates Golgi Elements with Vimentin IFs
FTCD fulfills five major criteria expected of a protein
participating in linking Golgi membranes and vimentin
filaments.
(1) FTCD localizes to relevant cellular compartments.
Endogenous FTCD is concentrated in the Golgi region by
immunofluorescence (Bloom and Brashear, 1989; Gao et
al., 1998; Hennig et al., 1998). However, reexamination of
FTCD distribution showed that endogenous and recombi-
nant FTCD localize to the Golgi stack and also to vimen-
tin filaments distributed throughout the cells. Interest-
ingly, in BFA-treated cells in which the Golgi complex is
partially disrupted, FTCD associates with filamentous
structures originating from the peri-Golgi region (Gao et
al., 1998). This result supports the idea that FTCD local-
izes to Golgi membranes but redistributes to filaments
when the Golgi complex is disrupted. Similar behavior has
been observed for plectin, which can interact with IFs and
with microtubules; in normal cells, plectin preferentially
colocalizes with IFs, but, in cells which do not contain vi-
mentin, plectin binds to microtubules (Svitkina et al.,
1996).
(2) FTCD associates with Golgi membranes. A propor-
tion of cellular FTCD is recovered with Golgi membranes
during fractionation, whereas the majority of FTCD is re-
covered in the supernatant cytosolic fraction (Bloom and
Brashear, 1989; Gao et al., 1998; Hennig et al., 1998). It is
most likely that FTCD binds to Golgi membranes through
protein–protein interactions, since FTCD does not contain
motifs capable of mediating direct lipid interactions. The
identity of the Golgi membrane receptor for FTCD is cur-
rently unknown, but the protein(s) mediating FTCD bind-
ing are not regulated by guanine exchange factors (for re-
view see Jackson and Casanova, 2000), since treatment of
cells with the drug BFA known to inhibit the activity of
such factors (Donaldson et al., 1992; Franco et al., 1998)
does not cause FTCD to dissociate from the membranes
(Gao et al., 1998).
(3) FTCD interacts with vimentin. We document the
novel finding that FTCD binds directly to vimentin sub-
units and to vimentin filaments, integrates into chimeric
FTCD/vimentin fibers, and markedly disrupts the vimen-
tin IF cytoskeleton. The interacting regions of FTCD and
vimentin have not been yet defined. Preliminary results
(data not shown) suggest that the native FTCD octamer
might be required for fiber formation since expression of
FT or CD domains alone does not lead to FTCD/vimentin
fiber formation.
(4) FTCD coordinately modulates the structure of the
Golgi complex and the vimentin IF cytoskeleton. A pre-
diction of a linking function for FTCD would be that
FTCD present in FTCD/vimentin fibers could interact
with Golgi elements and cause changes in Golgi morphol-
ogy. Indeed, in cells containing FTCD/vimentin fibers,
Golgi structure was disrupted to a varying degree with
Golgi membranes aligned along the FTCD/vimentin fi-
bers. It should be stressed that the formation of the FTCD/
vimentin fibers did not cause microtubule rearrangements
and, therefore, the disruption in Golgi structure was a di-
rect result of alterations in the vimentin IF cytoskeleton.
The coordinate change in organellar morphology as a re-
sult of cytoskeletal perturbation is not unique to the Golgi
complex and the IF cytoskeleton, and previous studies
have documented that overexpression of proteins linking
membranous organelles to the microtubule cytoskeleton
or the actin cytoskeletons cause changes in the cytoskele-
ton and the organelle. For example, coordinate perturba-
tions in Golgi structure and microtubule bundling were
observed in cells overexpressing the peripheral Golgi pro-
tein GMAP-210 (Infante et al., 1999). Similarly, in cellsThe Journal of Cell Biology, Volume 152, 2001 892
overexpressing the ER membrane protein CLIMP-63,
bundling of microtubules was paralleled by the rearrange-
ment of ER elements along the microtubule bundles
(Klopfenstein et al., 1998). Similarly, overexpression of
the actin-related protein centractin caused the formation
of abnormal centractin filaments and resulted in Golgi dis-
ruption and coalignment of Golgi elements on the centrac-
tin filaments (Holleran et al., 1996).
(5) FTCD promotes interaction between Golgi elements
and vimentin. We show that addition of FTCD preferen-
tially increases binding of Golgi elements and vimentin in
a centrifugation and solid state binding assays. Since
FTCD binds to Golgi elements and to vimentin, the sim-
plest interpretation of this result is that FTCD acts as a
molecular bridge linking Golgi membranes and vimentin.
However, we can not exclude the possibility that FTCD
might modify the Golgi surface in a way that allows direct
binding of Golgi elements to vimentin. In both cases,
FTCD facilitates the Golgi–vimentin interaction, and thus
fundamentally participates in the tethering event.
Our results support a model in which FTCD acts as a
structural–functional interface between Golgi elements
and the IF cytoskeleton. FTCD may modulate the exten-
sion of Golgi cisternae along IF filaments or may stabilize
the extended cisternae by directly anchoring them to IFs.
FTCD might also regulate the ability of Golgi elements to
interact with the various cytoskeletal systems by prevent-
ing or allowing the dynamic interactions of Golgi mem-
branes with the microtubule-based cytoskeletal system,
the spectrin/actin–based cytoskeletal system, or with other
Golgi-specific cytoskeletal proteins exemplified by p230
(Erlich et al., 1996), golgin-97 (Griffith et al., 1997), gian-
tin (Linstedt and Hauri, 1993), and GM130 (Nakamura et
al., 1995). Further analysis will be required to explore the
exact molecular mechanism of FTCD action.
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